{"id":3812,"date":"2026-02-10T03:31:04","date_gmt":"2026-02-10T03:31:04","guid":{"rendered":"http:\/\/blog.valuengine.com\/?p=3812"},"modified":"2026-02-10T03:32:07","modified_gmt":"2026-02-10T03:32:07","slug":"02-09-2026-valuengine-weekly-market-summary-commentary","status":"publish","type":"post","link":"http:\/\/blog.valuengine.com\/index.php\/02-09-2026-valuengine-weekly-market-summary-commentary\/","title":{"rendered":"02\/09\/2026 ValuEngine Weekly Market Summary & Commentary"},"content":{"rendered":"

Weekly Market Recap – Week Ending February 06, 2026<\/h3>\n
\n
\n

Market action last week depended heavily on where investors chose to look. Beneath largely unchanged headline index levels, sharp rotations continued across style, size, and geography. Value stocks outperformed growth by a wide margin, while large-cap technology names increasingly served as sources of funds for smaller-cap, value-oriented, and non-US equities. The result was a volatile but ultimately directionless week for broad US benchmarks, even as select sectors, international markets, and commodities delivered solid gains\u2014reinforcing the view that this remains a stock-picker\u2019s and allocator\u2019s market rather than a simple index-driven one.<\/p>\n<\/div>\n

Trade ValuEngine supported portfolio strategies, www.ValuEngineCapital.com<\/a><\/strong><\/p>\n

\"\"<\/p>\n

Free Trial: Research on over 5,000 stocks and 700 ETFs\u00a0HERE<\/a><\/strong><\/p>\n

\"\"<\/p>\n

Current ValuEngine reports on all covered 6000+ stocks and ETFs can be viewed HERE<\/a><\/strong><\/p>\n<\/div>\n

Strategy Note:<\/strong><\/h3>\n

Your perspective on how the stock market performed last week depended on which index ETF you used as your barometer. From feast to famine and back again, SPYM<\/strong> \u2014 the lowest fee S&P 500 ETF from State Street SPDRs \u2014 had a roller coaster week worthy of the end of the MacBeth soliloquy. It was \u201cfull of sound and fury, signifying nothing.\u201d<\/p>\n

It was a far worse week for large-cap growth investors as the Invesco Nasdaq-100 ETF (QQQ<\/strong>) lost roughly 2% and Vanguard Growth ETF (VUG<\/strong>) declined 2.7%, while Vanguard Value ETF (VTV<\/strong>) gained more than 3%. In short, it was a market of stocks focused on value opportunities tied to earnings rather than earnings growth \u2014 a classic stock-picker\u2019s market.<\/p>\n

In other markets, both iShares Emerging Markets ETF (EEM<\/strong>) and iShares MSCI EAFE ETF (EFA<\/strong>) gained more than 1.5%, while SPDR Gold MiniShares (GLDM<\/strong>) advanced 2.1%. Viewed through the lenses of SPY<\/strong> and QQQ<\/strong>, the \u201cSell America\u201d trade continues to work alongside the value-and-size rotation trade, with large Nasdaq-100 constituents increasingly used as sources of funds.<\/p>\n

We are now past the halfway point of earnings season, though it is far from over. Seventy-nine S&P 500 companies are scheduled to report this week. Among the most closely followed names is one 5-rated (Strong Buy) stock \u2014 Robinhood Markets (HOOD<\/strong>), our highest-rated broker-dealer. Five additional companies scheduled to report carry 4 (Buy) ratings, including health-care firms Moderna (MRNA<\/strong>), Gilead Sciences (GILD<\/strong>), and CVS Health (CVS<\/strong>), along with Ford Motor (F) and semiconductor equipment maker Applied Materials (AMAT<\/strong>).<\/p>\n

GILD is the second-largest holding in the Invesco Nasdaq Biotech ETF (IBBQ<\/strong>), our only Health-Care-related ETF rated 5 (Strong Buy). Notably, three other biotech stocks within IBBQ<\/strong> also carry 5 ratings: AstraZeneca (AZN<\/strong>), Argenx (ARGX<\/strong>), and Insmed (INSM<\/strong>). The first two align particularly well with a \u201cSell America\u201d allocation theme.<\/p>\n

The most efficient \u201cSell America\u201d ETF currently aligned with ValuEngine ratings is the AdvisorShares Dorsey Wright ADR ETF (AADR<\/strong>). The ETF itself is rated 5, and each of its ten largest holdings also carries a 5 rating. Brazilian aerospace and defense firm Embraer (ERJ<\/strong>) represents the ETF\u2019s largest position. Materials exposure is significant as well, with Gold Fields (GFI<\/strong>) holding the largest allocation among that group.<\/p>\n

Opinions vary on how long large U.S. growth stocks will continue to serve as sources of funds for other investments. For those who believe this trend is still in its early stages, several highly rated ETFs and stocks stand out below.<\/p>\n

 <\/p>\n

 <\/p>\n

www.ValuEngine.com<\/a>\u00a0(Valuengine, Inc) is a stock valuation and forecasting service founded by Ivy League finance academics. VE utilizes the most advanced quantitative techniques and analysis available to analyze over 4,200 US stocks, 700 US ETFs, and 1,000 Canadian stocks. Fair market valuations, forecast target prices, and buy\/hold\/sell recommendations are updated DAILY.<\/p>\n

www.ValuEngineCapital.com<\/a>\u00a0(ValuEngine Capital Management, LLC) is a Registered Investment Advisory firm that trades a variety of different portfolios based upon the ValuEngine.com research models. Each portfolio has a different risk\/return profile, so clients can be placed in strategies that fit their specific investment needs.<\/p>\n

BLOG.VALUENGINE.COM\u00a0<\/a>for the full history of ValuEngine.com financial blog posts<\/p>\n

____________________________________________________________________________<\/p>\n

Existing subscribers alert: ValuEngine has launched a completely redesigned and new website! Please check it out at\u00a0www.Valu<\/a>E<\/a>ngine.com<\/a><\/p>\n

Free trials available for new subscribers. Over 4,200 stocks and 600 ETFs covered.<\/p>\n

Full Two Week Free Trial\u00a0HERE<\/a><\/p>\n

5,000 stocks, 600 ETFs, 16 sector groups, and 140 industries updated on\u00a0www.ValuEngine.com<\/a>.<\/p>\n

Financial Advisory Services based on ValuEngine research available through\u00a0www.ValuEngineCapital.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Weekly Market Recap – Week Ending February 06, 2026 Market action last week depended heavily on where investors chose to look. Beneath largely unchanged headline index levels, sharp rotations continued across style, size, and geography. Value stocks outperformed growth by a wide margin, while large-cap technology names increasingly served as sources of funds for smaller-cap, … Read more<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[2996,2992,2991,347,2990,1135,2848,2997,2998,1704,2238,1761,2999,758,2988,2984,2985,1731,2365,2987,2989,1611,2993,2983,2832,2835,1471,2994,2995,106,2986,2006,1510,1713,1911,1748,2767,2769,2801,2757,1699,1687,1644,195,2709,28,1531,2981,1659,2982,2356,1700,2121,2085,2277,1849,2279,1887,1814,2707,1900,2276,2278],"_links":{"self":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3812"}],"collection":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/comments?post=3812"}],"version-history":[{"count":1,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3812\/revisions"}],"predecessor-version":[{"id":3815,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3812\/revisions\/3815"}],"wp:attachment":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/media?parent=3812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/categories?post=3812"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/tags?post=3812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}